Amicus Therapeutics is in the Business of Healing and Restoring Hope in Patients with Rare and Orphan Diseases

Cranbury New Jersey harbors one of the fastest growing biotechnology firms, Amicus Therapeutics Inc. The company was incepted in the year 2002 and has since grown to command international recognition with offices in Germany, Italy, France, Netherlands, and Spain as well as its global headquarters in the United Kingdom. It is also publicly traded under the FOLD symbol by NASDAQ, having held its first public offer in 2007.

 

Committed to Heal

 

Amicus Therapeutics was founded with the mission of developing therapies and treatments for rare and orphan diseases with the aim of bringing forth healing. The firm is technologically equipped and driven by high level of innovation to achieve its goals (http://www.phillypurge.com/2017/08/02/amicus-therapeutics-the-fight-against-the-rare-diseases/). The rare diseases community is the major inspiration to the leadership of the company to keep endeavoring to soar higher in its discoveries. Led by the Chairman of the board and Chief Executive Officer, John F. Crowley, the company is prepared to reach greater heights in science. The professionals at the firm are dedicated to the wellbeing of the patients. To the firm, Patients are at the heart of what they do.

 

Medicines and Therapies

 

Amicus Therapeutics has made great progress in the development of treatments for various diseases. Migalastat, which is in the last stages of development, is a drug developed by Amicus Therapeutics to treat Fabry disease. The use of the medicine is based on the genetic diagnosis of the ailment. The company is also in the process of creating a new therapy for Pompe disease, Fabry disease, and Lysosomal Storage Disorders (LSD) named novel enzyme replacement therapy (ERT) products. This development is based on the firm’s Chaperone-Advanced Replacement Therapy (CHART™) and its biologics. Another development by the firm, which is almost complete is SD-101 (YahooFinance). This therapy will be hopefully the first to get to the market for the treatment of Epidermolysis Bullosa (EB), which is a genetic connective tissue disorder.

 

Giving Back

 

Amicus Therapeutics is very committed to the eradication of rare disease communities. The company generously supports individual as well as non-profit organizations in the healthcare sector, focused on rare and orphan diseases programs. It is dedicated to supporting advocacy and public education for these ailments.

Find Out How Osteo Relief Institute Treats Patients Without Surgery

Arthritis disease commonly known as degenerative joint disease results from a combination of disorders. The disease is common to many people, and the symptoms are painful joints through cartilage degeneration. It is estimated that an average of 50 million people in the United States majority being women have been diagnosed with arthritis.

Although medical researchers have found no cure for arthritis, Osteo Relief Institute has identified different ways to help patients manage the pain. They advise patients to engage in their favorite activities to help them manage the painful joints.

Osteo Relief Institute, an organization based in New Jersey, is committed to offering lasting solutions to patients diagnosed with arthritis. Being independently owned, Osteo Relief Institute prides itself on having a team of highly trained and motivated staff who provide top-notch services in caring and communicating to patients. The institute has advanced equipment all approved by FDA to offer long-lasting solutions to patients. Their primary goal is to see their patients get effective treatment without necessarily having to go through surgery.

The Osteo Relief Institute has identified different types of arthritis (http://www.longislandosteorelief.com/). They include osteoarthritis which affects the elderly and rheumatoid arthritis which affects the young generation. The diseases cause the body to stag, and the person may end up using a wheelchair.

Osteo Relief Institute has introduced self-management measures to manage osteoarthritis. They include:

  • Frequent movement. Arthritis patients are advised to move around as keeping the joints stiff makes them more painful
  • Stretching out moments before going to bed to help the body reduce stiffness
  • Quitting smoking as it causes damage to tissues around the joints. Stopping smoking helps reduce swelling, body stiffness, and pain
  • Shedding off extra pounds as a lot of weight strains the body joints. Therefore, losing some weight will help reduce joint pain to the affected person.

Conclusion

Arthritis is a common disease that results from a variety of disorders. The disease affects the joints causing severe pain. There are two types of arthritis, and they include osteoarthritis and rheumatoid arthritis. Osteo Relief Institute in New Jersey has identified ways to manage arthritis without undergoing surgery. They include stretching before bed, moving around frequently, quitting smoking, and losing weight. The institute boasts about providing helpful solutions to arthritis patients.

More about Osteo Relief Institute on Facebook and LinkedIn